About Exact Imaging
Exact Imaging is a Healthcare company based in Las Vegas (United States) founded in 2003, and was acquired by Virginia Business Systems in December 2017. It operates as a prostate cancer imaging is enabled by micro-ultrasound technology. It operates on a HealthTech and Direct-to-Consumer (D2C) model. Exact Imaging has raised $4.2 million across 1 funding round from investors including Veddis, iGan Partners and Virginia Business Systems. Exact Imaging offers products and services including ExactVu Micro-Ultrasound System, EV29L Transducer, and FusionVu. Its focus areas include Medical Devices and Diagnostic Imaging. Its competitors include KOELIS, Triopsy, Clariflow, Focal Healthcare and UROCAM and 1 more; 3 of its 6 listed competitors have raised funding.
Company details
Exact Imaging is engaged in the development and distribution of high-resolution micro-ultrasound systems, primarily for urological applications. The companys flagship product, the ExactVu system, is designed to assist urologists in performing targeted prostate biopsies within standard workflows. Solutions are provided for both high-resolution and conventional imaging needs, covering procedures such as abdominal, testicular, and large prostate imaging. The technology is utilized in the healthcare sector, specifically targeting diagnostic imaging challenges with innovative tools and protocols like PRI-MUS for evidence-based targeting.
- Headquarters Las Vegas, United States
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website imagistxprostate.com
- Social LinkedIn X Facebook YouTube
- Acquired by Virginia Business Systems (Dec 2017)
- Legal Name Exact Imaging
- Total Equity Funding$4.2M (USD)
in 1 rounds
- Latest Funding Round$4.2M (USD), Series A
Dec 2013
- InvestorsVeddis
& 2 more
- Acquired byVirginia Business Systems
(Dec 2017)
Products & Services of Exact Imaging
Exact Imaging offers a comprehensive portfolio of products and services, including ExactVu Micro-Ultrasound System, EV29L Transducer, and FusionVu.
High-resolution ultrasound system for targeted prostate biopsies.
Transducer used for high-resolution prostate imaging procedures.
Software for MRI and ultrasound fusion in biopsies.
Apps and channels of Exact Imaging
its YouTube channel Exact Imaging has 31 subscribers.
Funding Insights of Exact Imaging
Exact Imaging has successfully raised a total of $4.2M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.2 million completed in December 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.2M
- Total Rounds 1
- Last Round Series A — $4.2M
- First Round $4.2M
(Dec 2013)
- Investors Count 2
All 1 funding rounds of Exact Imaging with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2013 | $4.2M | Series A | – | – |
3 investors in total: 3 institutional.
Investors in Exact Imaging
Exact Imaging has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Veddis, iGan Partners and Virginia Business Systems.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare-focused venture capital is provided by iGan Partners. | – | iganpartners.com | Toronto, Canada | |
Investment management and philanthropy services focused on long-term wealth growth and community impact. | 2006 | veddis.com | London, United Kingdom | |
Offers managed IT, printing, and workflow solutions to enhance business efficiency. | 1954 | vabusinesssystems.com | Richmond, United States |
Investor details for Exact Imaging
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Exact Imaging
3 dated milestones of Exact Imaging across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Exact Imaging is founded.
- Funding First funding round of $4.2M.
- Exit Acquired by Virginia Business Systems.
Competitors of Exact Imaging
Exact Imaging has 6 listed competitors in our database, 3 of them funded. They include KOELIS, Triopsy, Clariflow, Focal Healthcare and UROCAM, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| koelis.com | 2006 | Meylan, France | – | – | MRI/ultrasound fusion biopsy systems for prostate care are developed. | |
| triopsy.com | 2012 | Aurora, United States | $4.14M | – | Medical device for precise prostate cancer diagnosis is developed. | |
| clariflow.com | 2014 | New York, United States | $100,000 | – | Provides DIY test kits for benign prostatic hyperplasia (BPH). | |
| focalhealthcare.com | 2014 | Toronto, Canada | $870,000 | – | MRI/TRUS fusion systems for prostate biopsy guidance are developed. | |
| urocam.ca | 2017 | Vaughan, Canada | – | – | Develops innovative medical devices for prostate cancer diagnosis. | |
| cellda.com | 2018 | Uppsala, Sweden | – | – | Develops software tools for accurate prostate cancer diagnosis and analysis. |
Detailed competitors of Exact Imaging
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Oncology
10 companies that operate in the same segment as Exact Imaging (Oncology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | 2002 | Saint-genis-pouilly, Ain, France | USD 56.13 M | USD 235.08 M | – | |
Developer of small molecule drugs for the treatment of cancer and inflammatory disease | 2008 | Natick, Massachusetts, United States | USD 98.4 M | USD 146.07 M | 279 | |
Small molecule therapeutics are developed for cancer and rare diseases. | 2017 | New York, New York, United States | USD 229.6 M | – | – | |
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | 2016 | Cambridge, Massachusetts, United States | USD 223 M | USD 35.95 M | 110 | |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer | 2008 | Abingdon, Oxfordshire, United Kingdom | USD 601.28 M | USD 400.95 M | 493 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Exact Imaging
Complete news archive for Exact Imaging
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Exact Imaging
Exact Imaging was founded in 2003 and raised its 1st funding round 10 years after it was founded.
Exact Imaging is headquartered in Las Vegas, United States. It is registered at Las Vegas, Nevada, United States.
Exact Imaging is a funded company, having raised a total of $4.2M across 1 funding round to date. The company's 1st funding round was a Series A of $4.2M, raised on Dec 2013.
Exact Imaging is engaged in the development and distribution of high-resolution micro-ultrasound systems, primarily for urological applications. The companys flagship product, the ExactVu system, is designed to assist urologists in performing targeted prostate biopsies within standard workflows. Solutions are provided for both high-resolution and conventional imaging needs, covering procedures such as abdominal, testicular, and large prostate imaging. The technology is utilized in the healthcare sector, specifically targeting diagnostic imaging challenges with innovative tools and protocols like PRI-MUS for evidence-based targeting.
Exact Imaging's top competitors include KOELIS, Triopsy and Focal Healthcare.
Exact Imaging offers ExactVu Micro-Ultrasound System, EV29L Transducer, and FusionVu.
Exact Imaging has 3 investors. Key investors include Veddis, iGan Partners, and Virginia Business Systems.
Exact Imaging operates through Exact Imaging.
Yes. Exact Imaging was acquired by Virginia Business Systems in December 2017.